← Leaderboards
Theodore H Cohen
Harvard University (Sch Of Public Hlth)
$7,654,347
Attributed
$10,391,936
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,391,936 · 6
By mechanism
R01$6,899,233 · 3
DP2$2,672,711 · 1
K08$612,819 · 1
U54$207,173 · 1
Top collaborators
- Joshua A Salomon8 shared
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Megan B Murray$31,625,368
- Marc Lipsitch$19,606,666
- Christine A Petersen$6,352,199
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisTransmission ProcessPrevalenceInfectionDrug ResistanceEpidemicHeterogeneityCase FindingIncidencePathogenMycobacterium TuberculosisRisk FactorsGeographic LocationsCost EffectivenessCostInnovationProspectiveGenomicsProgramsCommunitiesMathematical ModelEconomic CostEffectivenessModels And Simulation
Grant awards (22)
Evolution, transmission, and control of drug-resistant tuberculosis$665,566
R01 · FY2025 · AI · contact PI
Evolution, transmission, and control of drug-resistant tuberculosis$758,488
R01 · FY2024 · AI · contact PI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$649,564
R01 · FY2023 · AI · contact PI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$768,475
R01 · FY2022 · AI · contact PI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$779,086
R01 · FY2021 · AI · contact PI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$870,052
R01 · FY2020 · AI · contact PI
Understanding and controlling antibiotic resistance$42,050
U54 · FY2018 · GM · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$562,005
R01 · FY2017 · AI · contact PI
Understanding and controlling antibiotic resistance$42,050
U54 · FY2017 · GM · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$579,864
R01 · FY2016 · AI · contact PI
Understanding and controlling antibiotic resistance$42,050
U54 · FY2016 · GM · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$591,645
R01 · FY2015 · AI · contact PI
Understanding and controlling antibiotic resistance$38,973
U54 · FY2015 · GM · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$674,488
R01 · FY2014 · AI · contact PI
Understanding and controlling antibiotic resistance$42,050
U54 · FY2014 · GM · contact PI
Prevalence, risk factors and consequences of complex M. Tuberculosis infections$2,672,711
DP2 · FY2010 · OD · contact PI
Molecular approaches for understanding TB dynamics$128,520
K08 · FY2008 · AI · contact PI
Molecular approaches for understanding TB dynamics$128,520
K08 · FY2007 · AI · contact PI
Molecular approaches for understanding TB dynamics$128,520
K08 · FY2006 · AI · contact PI
Molecular approaches for understanding TB dynamics$117,720
K08 · FY2005 · AI
Molecular approaches for understanding TB dynamics$78,489
K08 · FY2004 · AI
Molecular approaches for understanding TB dynamics$31,050
K08 · FY2004 · AI